Breaking the cellular delivery bottleneck: recent developments in direct cytosolic delivery of biologics
Open Access
- 2 July 2025
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in RSC Pharmaceutics
- Vol. 2 (5) , 850-864
Abstract
Proteins and nucleic acid therapeutics are delivered into cells via endosomal uptake/direct cytosolic entry. Endocytic pathways require endosomal escape, while direct fusion bypasses endosomes, enabling efficient delivery.Keywords
Funding Information
- National Institutes of Health (EB02264)
- National Institute of Allergy and Infectious Diseases (AI186027)
This publication has 113 references indexed in Scilit:
- Recent progress of cell-penetrating peptides as new carriers for intracellular cargo deliveryJournal of Controlled Release, 2014
- Oligonucleotide Conjugates for Therapeutic ApplicationsTherapeutic Delivery, 2013
- Direct Delivery of Functional Proteins and Enzymes to the Cytosol Using Nanoparticle-Stabilized NanocapsulesACS Nano, 2013
- Fluorescent labeling and modification of proteinsJournal of Chemical Biology, 2013
- Substrate-Initiated Synthesis of Cell-Penetrating Poly(disulfide)sJournal of the American Chemical Society, 2013
- Cyclic Peptide-Capped Gold Nanoparticles as Drug Delivery SystemsMolecular Pharmaceutics, 2012
- A Cell-penetrating Helical Polymer For siRNA Delivery to Mammalian CellsMolecular Therapy, 2012
- S413-PV Cell-Penetrating Peptide Forms Nanoparticle-Like Structures to Gain Entry Into CellsBioconjugate Chemistry, 2010
- The Use of Inhibitors to Study Endocytic Pathways of Gene Carriers: Optimization and PitfallsMolecular Therapy, 2010
- Cell-surface Accumulation of Flock House Virus-derived Peptide Leads to Efficient Internalization via MacropinocytosisMolecular Therapy, 2009